TCE2 Intrinsic Valuation and Fundamental Analysis - Celldex Therapeutics Inc

C	Celldex Therapeutics Inc SWB:TCE2	US
D	Data Communications Management Corp OTC:DCMDF	CA

Intrinsic Value

The intrinsic value for Celldex Therapeutics Inc (TCE2) under the Base Case is 3.47 EUR. Compared with the current market price of 28.3 EUR, the stock appears Overvalued by 88% .

DCF Value

N/A

Multiples-Based Value

€3.47

DCF Value

N/A

Multiples-Based Value

€3.47

Why combine DCF with multiples? What is Intrinsic Value?

TCE2 Intrinsic Value

Overvaluation 88%

Intrinsic Value

Price €28.3

Base Case Scenario

Track Buy Zone

20% below Intrinsic Value €2.78

Get notified when the price drops into your buy zone

Current Price €28.3

Intrinsic Value €3.47

Margin of Safety 20% €2.78

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Celldex Therapeutics Inc.

Explain Valuation